Boston Scientific (NYSE:BSX – Free Report) had its price objective boosted by Evercore ISI from $82.00 to $90.00 in a research note released on Tuesday, Benzinga reports. Evercore ISI currently has an outperform rating on the medical equipment provider’s stock. Several other equities research analysts have also recently weighed in on BSX. Raymond James increased […]

Boston Scientific (NYSE:BSX – Free Report) had its price objective boosted by Evercore ISI from $82.00 to $90.00 in a research note released on Tuesday, Benzinga reports. Evercore ISI currently has an outperform rating on the medical equipment provider’s stock. Several other equities research analysts have also recently weighed in on BSX. Raymond James increased […]

Onto Innovation (NYSE:ONTO – Free Report) had its price objective lifted by Oppenheimer from $260.00 to $275.00 in a report released on Tuesday, Benzinga reports. They currently have an outperform rating on the semiconductor company’s stock. A number of other analysts also recently weighed in on ONTO. Benchmark reissued a buy rating and set a […]

Agilent Technologies (NYSE:A – Free Report) had its price objective raised by Evercore ISI from $135.00 to $145.00 in a report issued on Tuesday morning, Marketbeat Ratings reports. The firm currently has an in-line rating on the medical research company’s stock. A has been the topic of several other research reports. Wells Fargo & Company […]

Accenture (NYSE:ACN – Free Report) had its price objective boosted by Barclays from $350.00 to $415.00 in a report published on Monday, Benzinga reports. The brokerage currently has an overweight rating on the information technology services provider’s stock. Several other brokerages have also issued reports on ACN. Royal Bank of Canada increased their target price […]